TIMOTHY KALMER: Open Payments
NPI 1316320724 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 68 payments from 9 companies in 2025. Trend: 2023 $981 · 2024 $706 · 2025 $1,393
Food & beverage: $1,282Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $326 |
| Teva Pharmaceuticals USA, Inc. | 10 | $246 |
| Lundbeck LLC | 12 | $237 |
| Alkermes, Inc. | 13 | $225 |
| ABBVIE INC. | 10 | $155 |
| Janssen Pharmaceuticals, Inc | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: INGREZZA, ARISTADA, ABILIFY ASIMTUFII, VRAYLAR, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, UZEDY.
Industry payments across WI — which companies pay providers there.
